Literature DB >> 5335875

Origin of serum and urinary methyltetrahydrofolate in man. Some observations on the methylfolate block hypothesis in Addisonian pernicious anaemia.

I Chanarin, A McLean.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5335875

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  8 in total

Review 1.  Significance of subnormal red-cell folate in thalassaemia.

Authors:  S C Tso
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

2.  Serum folic acid activity (L. casei) in Sephadex gel chromatography.

Authors:  T Markkanen; R L Pajula; P Himanen; S Virtanen
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

3.  Absorption and utilization of polyglutamyl forms of folate in man.

Authors:  J Perry; I Chanarin
Journal:  Br Med J       Date:  1968-11-30

4.  Malabsorption of folate polyglutamates in tropical sprue.

Authors:  A V Hoffbrand; T F Necheles; N Maldonado; E Horta; R Santini
Journal:  Br Med J       Date:  1969-05-31

5.  Effect of anticonvulsant drugs on the rate of folate catabolism in mice.

Authors:  D Kelly; D Weir; B Reed; J Scott
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

6.  Availability of monoglutamyl and polyglutamyl folates in normal subjects and in patients with coeliac sprue.

Authors:  C H Halsted; A M Reisenauer; B Shane; T Tamura
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

7.  A study of folate absorption and metabolism in man utilizing carbon-14--labeled polyglutamates synthesized by the solid phase method.

Authors:  C E Butterworth; C M Baugh; C Krumdieck
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

8.  Folate metabolism in man: the effect of malignant disease.

Authors:  A M Saleh; A E Pheasant; J A Blair; R N Allan; J Walters
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.